A lenvatinib-resistance-derived transcriptional program identifies metabolic identity remodeling associated with unfavorable survival in hepatocellular carcinoma
This paper identifies a transcriptional program from lenvatinib-resistant HCC cells that correlates with poor survival in an independent patient cohort, highlighting metabolic identity remodeling.
bioRxiv · Aug 24, 2026 · PreprintCancer Biology